![Francesca Chiodi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Francesca Chiodi active positions
Companies | Position | Start | End |
---|---|---|---|
IMED AB
![]() IMED AB Drugstore ChainsRetail Trade IMED AB is focused on the development and commercialization of fully human monoclonal antibodies for treatment of immune disorders and diseases such as ischemia/reperfusion injury, HIV and cancer. IMED’s unique antibodies modulate the natural process of cell death called apoptosis by selective and specific blocking or induction of central signaling pathways. IMED AB is a privately owned biotechnology company funded by Karolinska Development and LinkMed AB and intends to out-license its products to pharmaceutical companies. | Director/Board Member | 2009-11-25 | - |
Founder | 2009-11-25 | - |
Career history of Francesca Chiodi
Statistics
International
Sweden | 2 |
Operational
Director/Board Member | 1 |
Founder | 1 |
Sectoral
Retail Trade | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
IMED AB
![]() IMED AB Drugstore ChainsRetail Trade IMED AB is focused on the development and commercialization of fully human monoclonal antibodies for treatment of immune disorders and diseases such as ischemia/reperfusion injury, HIV and cancer. IMED’s unique antibodies modulate the natural process of cell death called apoptosis by selective and specific blocking or induction of central signaling pathways. IMED AB is a privately owned biotechnology company funded by Karolinska Development and LinkMed AB and intends to out-license its products to pharmaceutical companies. | Retail Trade |
- Stock Market
- Insiders
- Francesca Chiodi
- Experience